v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (1,568) $ (166)
Adjustments to reconcile loss to net cash used in operating activities:    
Depreciation and amortization 533 6
Share based compensation 76 (10)
Change in fair value of convertible loans and warrant liability 387 44
Financial expenses, net (2) 5
Changes in operating assets and liabilities:    
Other accounts receivable 64 9
Inventory (23)
Accounts payables 237 27
Accounts payables – related party (24) 6
Net cash used in operating activities (297) (103)
Cash flows from investing activities:    
Research and development expenses capitalization (1)
Net cash used in investing activities (1)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock
Proceeds from issuance of common stock net of issuance expenses 698 124
Net cash provided by financing activities 698 124
Foreign exchange on Cash and cash equivalents 2 (5)
Change in cash and cash equivalents 403 16
Cash and cash equivalents at beginning of period 408 79
Cash and cash equivalents at end of period $ 811 $ 95